| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Email: |
y.liu@mail.biobiopha.com |
| Products Intro: |
Product Name:Dehydroheliobuphthalmin
CAS:103001-05-4
Purity:>97.0% Package:5mg Remarks:BBP01300
|
|
| | Dehydroheliobuphthalmin Basic information |
| Product Name: | Dehydroheliobuphthalmin | | Synonyms: | (E)-(1,3-Benzodioxol-5-ylmethyl)(1,3-benzodioxol-5-ylmethylene)butanedioic acid dimethyl ester;Butanedioic acid, (1,3-benzodioxol-5-ylmethyl)(1,3-benzodioxol-5-ylmethylene)-, dimethyl ester, (E)- (9CI) | | CAS: | 103001-05-4 | | MF: | C22H20O8 | | MW: | 412.3894 | | EINECS: | | | Product Categories: | | | Mol File: | 103001-05-4.mol |  |
| | Dehydroheliobuphthalmin Chemical Properties |
| Boiling point | 582.3±50.0 °C(Predicted) | | density | 1.360±0.06 g/cm3(Predicted) | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder |
| | Dehydroheliobuphthalmin Usage And Synthesis |
| Description | Dehydroheliobuphthalmin has significant neuroprotective activities against glutamate-
induced neurotoxicity. | | Uses | (7E)-7,8-Dehydroheliobuphthalmin is a lignan derivative from Platycladus orientalis[1]. | | References | [1] Li, Gang, et al. Separation and extraction of lignans derivatives from Platycladus orientalis. Patent CN113666902. 2021-11-19. |
| | Dehydroheliobuphthalmin Preparation Products And Raw materials |
|